Scott M. Rocklage, PhD, is one of the most respected businessmen of his time. He joined 5 AM Ventures as a Venture Partner back in 2003. He then became the company’s Managing Partner a year later.
Dr. Rocklage prides himself in his wealth of experience in healthcare management, which spans over three decades. He has also been charged with strategic leadership roles in the past. These experiences helped him oversee the approval of several drug applications in the United States, namely Omniscan, Cubicin and Teslascan.
With his vast knowledge and experience in the healthcare sector, Dr. Rocklage has also had the privilege of serving in various capacities in different organizations. For example, he was the CEO and Chair of Cubist Pharmaceuticals.
He was also the CEO and President of a company called Nycomed Salutar. His positions also include holding R&D positions in companies such as Catalytca.
Rocklage’s board memberships include NASDAQ-RLYP, as well as Novira. Currently, he serves on the boards of Semprus, Miikana, Epirus and Pulmatrix among other organizations. Based in Boston, Dr. Rocklage has also invented and co-invented over 30 patents in the US alone. He has also peer-reviewed numerous publications in his lifetime. Read more: Scott Rocklage | Rennovia and Scott Rocklage | Crunchbase
When asked about his business, and the inspiration behind it, Dr. Rocklage points towards his love for the sciences. His firm is focused on science-based venture capital, and he borrows ideas mainly from like-minded entrepreneurs.
His firm partners with scientists and other professionals in the healthcare sector, to assist them in shaping and bringing to life ideas that would potentially treat unique ailments.
Rocklage considers time-management and being organized as contributors to his productivity and ultimate success. He also finds that staying true to your business can help you grow your business even in the face of adversity.